Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

140
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
140
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

90
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
90
Actuarial Approach01:20

Actuarial Approach

60
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
60
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

176
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
176
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
Cancer Survival Analysis01:21

Cancer Survival Analysis

327
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
327

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxygen Distribution and Segregation at Grain Boundaries in Nb and Ta-Encapsulated Nb Thin Films for Superconducting Qubits.

ACS nano·2026
Same author

A Comparison of Methods for Treatment Selection in Seamless Phase II/III Design.

Biometrical journal. Biometrische Zeitschrift·2026
Same author

Improved Dark Photon Sensitivity from a Superconducting-Radio-Frequency-Cavity Experiment.

Physical review letters·2026
Same author

Atomic-Scale Characterization and Electronic Properties of Gold-Capped Niobium Films for Superconducting Qubits.

ACS nano·2026
Same author

Graph Based, Adaptive, Multiarm, Multiple Endpoint, Two-Stage Designs.

Statistics in medicine·2025
Same author

Extending Multiple Testing With Unknown Test Dependency via the CoCo Test: With Applications to Cancer Studies.

Pharmaceutical statistics·2025
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
Same journal

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same journal

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same journal

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Statistics in medicine·2026
Same journal

Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging-Enhanced Adaptive Sampling.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: May 31, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K

Testing One Primary and Two Secondary Endpoints in a Two-Stage Group Sequential Trial With Extensions.

Ajit C Tamhane1, Dong Xi2, Cyrus R Mehta3

  • 1Northwestern University, Evanston, Illinois, USA.

Statistics in Medicine
|January 24, 2025
PubMed
Summary
This summary is machine-generated.

This study develops powerful statistical methods for testing secondary endpoints after a primary endpoint is significant in clinical trials. Normal theory tests offer higher power than p-value based methods by accounting for endpoint correlations and gatekeeping effects.

Keywords:
Hochberg procedureHolm procedureLan‐DeMets flexible boundary approachO'Brien‐Fleming boundaryPocock boundaryclosed proceduresgatekeeping

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

426
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K

Related Experiment Videos

Last Updated: May 31, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

426
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Group sequential procedures are crucial for adaptive clinical trial designs, allowing early stopping for efficacy or futility.
  • Testing multiple secondary endpoints conditional on primary endpoint significance requires careful statistical control to maintain Type I error rates.
  • Existing p-value based methods (Holm, Hochberg) are straightforward but may lack power due to ignoring endpoint correlations and gatekeeping effects.

Purpose of the Study:

  • To develop normal theory analogs for testing multiple secondary endpoints in two-stage group sequential trials.
  • To incorporate the gatekeeping effect of the primary endpoint and correlations between endpoints into the statistical testing procedures.
  • To compare the power and Type I error rates of the proposed normal theory procedures against existing p-value based methods.

Main Methods:

  • Development of normal theory based closed procedures for testing multiple secondary hypotheses.
  • Determination of normal theory boundaries using the least favorable configuration of correlations, eliminating the need for prior knowledge of correlations.
  • Comparison of secondary powers between normal theory and p-value based procedures, including sensitivity analyses for unequal information times.

Main Results:

  • Normal theory analogs demonstrate higher statistical power compared to p-value based Holm and Hochberg procedures.
  • The proposed normal theory methods effectively account for the gatekeeping effect and endpoint correlations, leading to improved power.
  • Normal theory procedures are computationally intensive beyond two secondary endpoints or stages, while p-value based methods remain applicable.

Conclusions:

  • Normal theory based procedures provide a more powerful approach for testing multiple secondary endpoints in specific clinical trial settings.
  • These methods offer a valuable alternative when accurate correlation information is unavailable, relying on least favorable configurations.
  • The study highlights the trade-offs between power and computational complexity in designing group sequential trials with multiple secondary endpoints.